<DOC>
	<DOCNO>NCT00002753</DOCNO>
	<brief_summary>RATIONALE : Monoclonal antibody locate tumor cell either kill deliver tumor-killing substance without harm normal cell . PURPOSE : Phase I trial determine effectiveness monoclonal antibody treat patient recurrent glioma .</brief_summary>
	<brief_title>Monoclonal Antibody Therapy Treating Patients With Recurrent Gliomas</brief_title>
	<detailed_description>OBJECTIVES : I. Assess toxic effect intracystic administration iodine-131-labeled anti-tenascin monoclonal antibody 81C6 . II . Identify objective therapeutic response treatment patient recurrent cystic anaplastic glioma . OUTLINE : Radioimmunotherapy . Iodine-131-Labeled Anti-Tenascin Monoclonal Antibody 81C6 , 131I-81C6 . PROJECTED ACCRUAL : Three six patient enter dose study .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm supratentorial anaplastic glioma recurrent cyst require aspiration symptom control Measurable cystic lesion confirm contrastenhanced CT MRI At least 3 month since radiotherapy site measurable disease unless unequivocal evidence tumor progression Neoplastic cell reactivity tenascin demonstrate immunohistology either polyclonal rabbit antibody monoclonal murine antibody PATIENT CHARACTERISTICS : Age : 3 Performance status : Karnofsky 50100 % Hematopoietic : Absolute neutrophil count great 1,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL AST le 1.5 time normal Alkaline phosphatase less 1.5 time normal Renal : Creatinine le 1.2 mg/dL Other : Negative pregnancy test Effective contraception require fertile woman PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 6 week since antineoplastic chemotherapy unless unequivocal evidence tumor progression Endocrine therapy : Corticosteroids allow low possible dose dose stable least 10 day prior entry Radiotherapy : See Disease Characteristics Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>recurrent childhood brain tumor</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>